Nomograms including the UBC Rapid test to detect primary bladder cancer based on a multicentre dataset.

Objectives: To evaluate the clinical utility of the urinary bladder cancer antigen test UBC Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify patients at high risk of primary BC.

Patients And Methods: Data from 1787 patients from 13 participating centres, who were tested between 2012 and 2020, including 763 patients with BC, were analysed. Urine samples were analysed with the UBC Rapid test.

Development of foam-like emulsion phases in porous media flow.

Hypothesis: While surfactant solutions mobilize residual oil under optimal conditions by lowering the water-oil interfacial tension, emulsion phases outside of the optimum tend to be immobile. How are mobility and texture of such phases related, and how can the stability of these phases be understood? Can non-optimized surfactant solutions improve displacement processes through mobility control?

Experiment: Emulsification and miscibility during surfactant flooding were investigated in microfluidics with generic oil and surfactant solutions. The salt concentration was varied in an exceptionally wide range across the optimal displacement conditions.

Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer.

Objective: Several commercial point-of-care (POC) tests are available for urine-based detection of bladder cancer (BC). However, these tests are restricted to dichotomized results (positive or negative), which limits their diagnostic value. Quantitative protein-based tests offer improved risk stratification but require complex methods restricted to specialized centers.